久精品免费观看国产33,精品国产电影在线看免,在线观看aⅴ免费,久久99久久久一本精品

        • 您當(dāng)前所在位置:首頁(yè) > 資訊信息 > 新品上市
          F-GSH-PEG-DSPE修飾脂質(zhì)體的合成以及表征
          發(fā)布時(shí)間:2025-07-18     作者:zyl   分享到:

          文獻(xiàn):Synthesis and Evaluation of a Novel Lipophilic Folate Receptor Targeting Ligand

          作者:YING LIU, SONGLIN XU, LESHENG TENG, BRYANT YUNG, JING ZHU, HONG DING and ROBERT J. LEE

          文獻(xiàn)鏈接:https://ar.iiarjournals.org/content/31/5/1521.short

          摘要:

          Background: Folate receptor (FR)-targeted liposomes have been investigated as delivery vehicles for anticancer drugs. A novel lipophilic FR ligand, folate-glutathione-polyethyleneglycol-distearoyl phosphatidylethanolamine (F-GSH-PEG-DSPE), was synthesized, incorporated into liposomes and evaluated for FR targeting efficiency. These liposomes were then evaluated as carriers of the chemotherapy agent vincristine (VIN). Materials and Methods: F-GSH-PEG-DSPE was synthesized and FR-targeted liposomes loaded with either calcein (F-L-Calcein) or VIN (F-L-VIN) were prepared by thin film hydration followed by polycarbonate membrane extrusion and, in the case of VIN, by remote loading. To assess liposome stability, the uptake of F-L-VIN in KB (FR+) cancer cells was measured after storage under 4°C for 3 months. Comparative pharmacokinetic studies were carried out with F-L-VIN and L-VIN (non-targeted control liposomes). Results: F-L-Calcein showed significantly higher cellular uptake in KB cells compared to non-targeted liposomes. In addition, F-L-VIN showed enhanced cytotoxicity in KB cells in vitro compared to control liposomes. Pharmacokinetic parameters indicated that both F-L-VIN and control liposomes had higher area under the curve (AUC), mean residence time (MRT), elimination half life (t1/2-β) and lower total body clearance (CL) than those of free VIN, while there were no significant differences between these liposomal formulations. Conclusion: F-GSH-PEG-DSPE is effective as a novel ligand for the synthesis of FR-targeted liposomes.

          F-GSH-PEG-DSPE

          合成了一種新型親脂性FR配體,葉酸-谷胱甘肽聚乙二醇二硬脂酰磷脂酰乙醇胺(F-GSH-PEG-DSPE),將其摻入脂質(zhì)體中,并評(píng)估了FR靶向效率。然后將這些脂質(zhì)體作為化療藥物長(zhǎng)春新堿(VIN)的載體進(jìn)行評(píng)估。

          材料和方法:合成F-GSH-PEG-DSPE,通過(guò)薄膜水合、聚碳酸酯膜擠出和遠(yuǎn)程加載制備負(fù)載鈣黃綠素(F-L-calcein)或VIN(F-L-VIN)的FR靶向脂質(zhì)體。

          為了評(píng)估脂質(zhì)體的穩(wěn)定性,在4°C下儲(chǔ)存3個(gè)月后,測(cè)量KB(FR+)細(xì)胞對(duì)F-L-VIN的攝取。用F-L-VIN和L-VIN(非靶向?qū)φ罩|(zhì)體)進(jìn)行了比較藥代動(dòng)力學(xué)研究。

          結(jié)果:與非靶向脂質(zhì)體相比,F(xiàn)-L-Calcein在KB細(xì)胞中的細(xì)胞攝取明顯更高。此外,與對(duì)照脂質(zhì)體相比,F(xiàn)-L-VIN在體外KB細(xì)胞中顯示出增強(qiáng)的細(xì)胞毒性。

          藥代動(dòng)力學(xué)參數(shù)表明,F(xiàn)-L-VIN和對(duì)照脂質(zhì)體的曲線下面積(AUC)、平均停留時(shí)間(MRT)、消除半衰期(t1/2-β)和全身清除率(CL)均高于游離VIN,但這些脂質(zhì)體制劑之間沒(méi)有顯著差異。

          結(jié)論:F-GSH-PEG-DSPE作為合成FR靶向脂質(zhì)體的新型配體是有效的。

          相關(guān)推薦:

          DSPE-PEG-Biotin

          DSPE-PEG-Boronate

          DSPE-PEG-CH2COOH

          DSPE-PEG-COOH

          DSPE-PEG-Cy3

          DSPE-PEG-Cy5

          DSPE-PEG-DBCO

          DSPE-PEG-FITC

          DSPE-PEG-Folate

          DSPE-PEG-IA

          DSPE-PEG-Mal

          以上文章內(nèi)容來(lái)源各類期刊或文獻(xiàn),如有侵權(quán)請(qǐng)聯(lián)系我們刪除!


          庫(kù)存查詢